Return On Assets in % of Lipocine Inc. from Q2 2013 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lipocine Inc. quarterly/annual Return On Assets history and change rate from Q2 2013 to Q3 2025.
  • Lipocine Inc. Return On Assets for the quarter ending 30 Sep 2025 was -28 %, a 60.2% decline year-over-year.
  • Lipocine Inc. annual Return On Assets for 2024 was 0 %.
  • Lipocine Inc. annual Return On Assets for 2023 was -58 %, a 126% decline from 2022.
  • Lipocine Inc. annual Return On Assets for 2022 was -25 %, a 1838% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Lipocine Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -28 -11 -60.2% 01 Jul 2025 30 Sep 2025
Q2 2025 -21 +13 +37.9% 01 Apr 2025 30 Jun 2025
Q1 2025 -24 +10 +28.4% 01 Jan 2025 31 Mar 2025
Q4 2024 0 +58 01 Oct 2024 31 Dec 2024
Q3 2024 -17 +34 +65.8% 01 Jul 2024 30 Sep 2024
Q2 2024 -35 -1 -3.5% 01 Apr 2024 30 Jun 2024
Q1 2024 -34 -6 -18.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -58 -32 -1.3% 01 Oct 2023 31 Dec 2023
Q3 2023 -51 -60 -6.7% 01 Jul 2023 30 Sep 2023
Q2 2023 -34 -42 -5.5% 01 Apr 2023 30 Jun 2023
Q1 2023 -29 -27 -17.1% 01 Jan 2023 31 Mar 2023
Q4 2022 -25 -24 -18.4% 01 Oct 2022 31 Dec 2022
Q3 2022 9 +52 01 Jul 2022 30 Sep 2022
Q2 2022 7 +59 01 Apr 2022 30 Jun 2022
Q1 2022 -1 +58 +97.3% 01 Jan 2022 31 Mar 2022
Q4 2021 -1 +87 +98.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -43 +45 +51.1% 01 Jul 2021 30 Sep 2021
Q2 2021 -51 +39 +43.4% 01 Apr 2021 30 Jun 2021
Q1 2021 -59 +20 +25.3% 01 Jan 2021 31 Mar 2021
Q4 2020 -88 -23 -35.8% 01 Oct 2020 31 Dec 2020
Q3 2020 -88 -25 -38.8% 01 Jul 2020 30 Sep 2020
Q2 2020 -90 -34 -58.6% 01 Apr 2020 30 Jun 2020
Q1 2020 -80 -27 -51.2% 01 Jan 2020 31 Mar 2020
Q4 2019 -65 -19 -40.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -64 -12 -22.1% 01 Jul 2019 30 Sep 2019
Q2 2019 -57 +2 +2.9% 01 Apr 2019 30 Jun 2019
Q1 2019 -52 +15 +21.7% 01 Jan 2019 31 Mar 2019
Q4 2018 -46 +32 +40.9% 01 Oct 2018 31 Dec 2018
Q3 2018 -52 +16 +23.3% 01 Jul 2018 30 Sep 2018
Q2 2018 -58 +2 +3.6% 01 Apr 2018 30 Jun 2018
Q1 2018 -67 -10 -18.2% 01 Jan 2018 31 Mar 2018
Q4 2017 -78 -20 -33.5% 01 Oct 2017 31 Dec 2017
Q3 2017 -68 -12 -21.9% 01 Jul 2017 30 Sep 2017
Q2 2017 -61 -4 -6.7% 01 Apr 2017 30 Jun 2017
Q1 2017 -57 -10 -19.9% 01 Jan 2017 31 Mar 2017
Q4 2016 -58 -17 -39.4% 01 Oct 2016 31 Dec 2016
Q3 2016 -56 -11 -23.7% 01 Jul 2016 30 Sep 2016
Q2 2016 -57 -13 -29.7% 01 Apr 2016 30 Jun 2016
Q1 2016 -47 +12 +20.3% 01 Jan 2016 31 Mar 2016
Q4 2015 -42 +17 +28.8% 01 Oct 2015 31 Dec 2015
Q3 2015 -45 +8 +14.8% 01 Jul 2015 30 Sep 2015
Q2 2015 -44 +6 +11.6% 01 Apr 2015 30 Jun 2015
Q1 2015 -59 -14 -29.5% 01 Jan 2015 31 Mar 2015
Q4 2014 -59 -8 -16.4% 01 Oct 2014 31 Dec 2014
Q3 2014 -53 -42 -3.8% 01 Jul 2014 30 Sep 2014
Q2 2014 -49 -142 -1.5% 01 Apr 2014 30 Jun 2014
Q1 2014 -46 01 Jan 2014 31 Mar 2014
Q4 2013 -50 01 Oct 2013 31 Dec 2013
Q3 2013 -11 01 Jul 2013 30 Sep 2013
Q2 2013 92 01 Apr 2013 30 Jun 2013

Lipocine Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 0 +58 01 Jan 2024 31 Dec 2024
2023 -58 -32 -1.3% 01 Jan 2023 31 Dec 2023
2022 -25 -24 -18.4% 01 Jan 2022 31 Dec 2022
2021 -1 +87 +98.5% 01 Jan 2021 31 Dec 2021
2020 -88 -23 -35.8% 01 Jan 2020 31 Dec 2020
2019 -65 -19 -40.8% 01 Jan 2019 31 Dec 2019
2018 -46 +32 +40.9% 01 Jan 2018 31 Dec 2018
2017 -78 -20 -33.5% 01 Jan 2017 31 Dec 2017
2016 -58 -17 -39.4% 01 Jan 2016 31 Dec 2016
2015 -42 +17 +28.8% 01 Jan 2015 31 Dec 2015
2014 -59 -8 -16.4% 01 Jan 2014 31 Dec 2014
2013 -50 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.